These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37248704)

  • 1. Development and validation of a ligand-receptor pairs signature to predict outcome and provide a therapeutic strategy in gastric cancer.
    Yang W; Zhao X; Duan L; Niu L; Zhang Y; Zhou W; Li Y; Chen J; Fan A; Xie Q; Liu J; Han Y; Fan D; Hong L
    Expert Rev Mol Diagn; 2023; 23(7):619-634. PubMed ID: 37248704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma.
    Liu F; Wang P; Sun W; Jiang Y; Gong Q
    Front Immunol; 2022; 13():874056. PubMed ID: 35734169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-ligand pair typing and prognostic risk model for papillary thyroid carcinoma based on single-cell sequencing.
    Cao ZX; Weng X; Huang JS; Long X
    Front Immunol; 2022; 13():902550. PubMed ID: 35935973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular subtypes of triple negative breast cancer were defined and a ligand-receptor pair score model was constructed by comprehensive analysis of ligand-receptor pairs.
    Pan W; Song K; Zhang Y; Yang C; Zhang Y; Ji F; Zhang J; Shi J; Wang K
    Front Immunol; 2022; 13():982486. PubMed ID: 36119101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
    Hu B; Meng Y; Qu C; Wang BY; Xiu DR
    Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single cell and bulk RNA sequencing identifies tumor microenvironment subtypes and chemoresistance-related IGF1
    Jia X; Li Z; Zhou R; Feng W; Yi L; Zhang H; Chen B; Li Q; Huang S; Zhu X
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167123. PubMed ID: 38484940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular subtyping for lung adenocarcinoma and a novel prognostic model based on ligand-receptor pairs.
    Li D; Ma X; Ou S
    Adv Med Sci; 2022 Sep; 67(2):316-327. PubMed ID: 36054998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Analysis of Ligand-receptor Interactions in Colon Adenocarcinoma to Identify of Tumor Microenvironment Oxidative Stress and Prognosis Model.
    Hu J; Zhu W; Wang W; Yue X; Zhao P; Kong D
    Curr Med Chem; 2024; 31(30):4912-4934. PubMed ID: 37605402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineation of colorectal cancer ligand-receptor interactions and their roles in the tumor microenvironment and prognosis.
    Lin H; Xia L; Lian J; Chen Y; Zhang Y; Zhuang Z; Cai H; You J; Guan G
    J Transl Med; 2021 Dec; 19(1):497. PubMed ID: 34876143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
    Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
    Front Immunol; 2022; 13():977338. PubMed ID: 36159818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients.
    Gao J; Huo S; Zhang Y; Zhao Z; Pan H; Liu X
    Cancer Med; 2023 Jan; 12(1):913-929. PubMed ID: 35621244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer.
    Liu ZY; Xin L
    Medicine (Baltimore); 2023 Sep; 102(39):e35027. PubMed ID: 37773804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
    Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
    Front Immunol; 2022; 13():951214. PubMed ID: 35967313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Ligand-Receptor Pair in Bladder Cancer Develops a Validated Scoring Model for Prognosis and Treatment Response.
    Wang C; Wan H; Zhang H; Yang B; Huang WK; Sun W
    Front Cell Dev Biol; 2022; 10():915798. PubMed ID: 35784457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel lipid metabolism-related gene signature to predict outcomes and the tumor immune microenvironment in gastric cancer by integrated analysis of single-cell and bulk RNA sequencing.
    Zhang J; Wang H; Tian Y; Li T; Zhang W; Ma L; Chen X; Wei Y
    Lipids Health Dis; 2023 Dec; 22(1):212. PubMed ID: 38042786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new risk model based on a 11-m
    Lei L; Li N; Yuan P; Liu D
    BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.